| Dr Raven Nicole Necaise, PT, DPT | |
|
12261 Highway 49 Ste 1, Gulfport, MS 39503-2976 | |
| (228) 265-7185 | |
| Not Available |
| Full Name | Dr Raven Nicole Necaise |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 12261 Highway 49 Ste 1, Gulfport, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124892583 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-7653 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Raven Nicole Necaise, PT, DPT 12261 Highway 49 Ste 1, Gulfport, MS 39503-2976 Ph: () - | Dr Raven Nicole Necaise, PT, DPT 12261 Highway 49 Ste 1, Gulfport, MS 39503-2976 Ph: (228) 265-7185 |
News Archive
ACT for NIH: Advancing Cures Today announced a national, non-partisan effort to seek an immediate, significant funding increase for the National Institutes of Health (NIH) to enhance life-saving medical research for patients around the world.
INTEGRA has expanded the range of interchangeable pipetting heads for its market-leading handheld VIAFLO 96/384 electronic pipettes.
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH).
Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection.
› Verified 7 days ago
Jacqueline Dang Truong, PT, DPT, OCS Physical Therapist Medicare: Medicare Enrolled Practice Location: 15476b Dedeaux Rd, Gulfport, MS 39503 Phone: 228-539-3232 Fax: 228-539-3230 | |
Elizabeth Anderson, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1530 Broad Ave, Gulfport, MS 39501 Phone: 228-864-6544 | |
Exceed Physical Therapy, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 12261 Highway 49 Ste 1, Gulfport, MS 39503 Phone: 228-861-4218 | |
Mr. Mark Orson Harris, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15476a Dedeaux Rd, Gulfport, MS 39503 Phone: 228-539-3232 | |
Mr. Gabriel Ezechukwu Ndukwu, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4500 13th St Ste 900, Gulfport, MS 39501 Phone: 228-822-6956 | |
Timothy Joseph Kruchowsky, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 45th Ave Ste B, Gulfport, MS 39501 Phone: 228-864-1212 Fax: 228-868-2323 | |
Daniel Courtenay, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 12261 Highway 49 Ste 1, Gulfport, MS 39503 Phone: 228-860-9676 Fax: 228-860-9676 |